Following the rerating, Danaher shares seem to have found their footing, with downward [earnings] estimate revisions ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

Shares of Danaher Corp. DHR slid 1.28% to $212.07 Friday, on what proved to be an all-around positive trading session for the ...

We recently published a list of Jim Cramer’s Latest Calls: Top 10 Stocks. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other big-cap stocks that are plunging so far in 2025. The market has been reversing its gains ...

AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks. Bourgeon Capital Management LLC is an investment advisory firm headquartered ...

In a shareholder-friendly move, Danaher Corporation DHR has announced a hike in its dividend payout. The company increased its quarterly dividend by 18.5% to 32 cents per share (annually: $1.28). The ...

Shares of Danaher Corp. DHR slipped 3.23% to $205.23 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...